genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Klebsiella
Genome Editing
Bacterial Antiviral Mechanism Triggers Growth Arrest through de novo Neo Gene
Drug Discovery
Antibiotic Slays Gram-Negative Bacteria, Spares Commensals in Mice
Drug Discovery
Antibiotic Hits Novel Target, a Lipid Enzyme, Defeats Resistant Bacteria in Mice
Drug Discovery
Natural Product Antibiotic Discovered 80 Years Ago Kills Drug Resistant Bacteria in Mice
Drug Discovery
Drug-Resistant Bacterial Pathogens Collaborate to Boost Virulence
Drug Discovery
Superbugs Thought to be Invincible Can Succumb to Antibiotic Combinations
Drug Discovery
Spero Wins Up to $54M Toward Development of Lead Antibiotic SPR994 for UTI
News
Invisible and Present Danger
Infectious Diseases
Bacteria Resistant to Colistin Present Serious Clinical Challenge
Drug Discovery
Gates Foundation Supports Achaogen’s Antibacterial Platform with $20.5M
1
2
Page 1 of 2
Scroll Up